The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
Top Cited Papers
- 1 June 2018
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 102 (6), 900-931
- https://doi.org/10.1097/tp.0000000000002191
Abstract
Despite recent advances, cytomegalovirus (CMV) infections remain one of the most common complications affecting solid organ transplant recipients, conveying higher risks of complications, graft loss, morbidity, and mortality. Research in the field and development of prior consensus guidelines supported by The Transplantation Society has allowed a more standardized approach to CMV management. An international multidisciplinary panel of experts was convened to expand and revise evidence and expert opinion-based consensus guidelines on CMV management including prevention, treatment, diagnostics, immunology, drug resistance, and pediatric issues. Highlights include advances in molecular and immunologic diagnostics, improved understanding of diagnostic thresholds, optimized methods of prevention, advances in the use of novel antiviral therapies and certain immunosuppressive agents, and more savvy approaches to treatment resistant/refractory disease. The following report summarizes the updated recommendations.Keywords
This publication has 339 references indexed in Scilit:
- An International Multicenter Performance Analysis of Cytomegalovirus Load TestsClinical Infectious Diseases, 2012
- Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trialThe Lancet, 2011
- 24 Weeks of Valganciclovir Prophylaxis in Children After Renal Transplantation: A 4-Year ExperienceTransplantation, 2011
- Impact of Prophylactic Versus Preemptive Valganciclovir on Long-Term Renal Allograft OutcomesTransplantation, 2010
- Cytomegalovirus Immunoglobulin Decreases the Risk of Cytomegalovirus Infection but not Disease After Pediatric Lung TransplantationThe Journal of Heart and Lung Transplantation, 2009
- The Risk, Prevention, and Outcome of Cytomegalovirus After Pediatric Lung TransplantationTransplantation, 2009
- Vaccine Prevention of Maternal Cytomegalovirus InfectionNew England Journal of Medicine, 2009
- Increased Mortality After Pulmonary Fungal Infection Within the First Year After Pediatric Lung TransplantationThe Journal of Heart and Lung Transplantation, 2008
- Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirusVaccine, 2007
- Guide to Development of Practice GuidelinesClinical Infectious Diseases, 2001